Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Neutropenia“
Suchtreffer
Begriffe & Kennungen
Bimzelx · 4.8 · Neutropenia
Eintrag öffnenBimzelx · 4.8 · Neutropenia was observed with bimekizumab in Phase III clinical studies in plaque psoriasis. Over the entire t
Eintrag öffnenBimzelx · 4.8 · The frequency of neutropenia in PsA, axSpA (nr-axSpA and AS) and HS clinical studies was similar to that obser
Eintrag öffnenBlincyto · 4.8 · The most frequently reported serious adverse reactions were pyrexia (11.4%), febrile neutropenia (11.4%), cyto
Eintrag öffnenBlitzima · 4.8 · In GPA/MPA Study 2, the incidence of all-grade neutropenia was 0% for rituximab-treated patients vs. 5% for az
Eintrag öffnenBlitzima · 4.8 · Neutropenia Events of neutropenia were observed with rituximab treatment, the majority of which were transient
Eintrag öffnenBlitzima · 4.8 · Neutropenia In GPA/MPA Study 1, 24% of patients in the rituximab group (single course) and 23% of patients in
Eintrag öffnenBlitzima · 4.8 · Neutropenic events, including severe late onset and persistent neutropenia, have been rarely reported in the p
Eintrag öffnenBosulif · 4.8 · Of the 209 (15.2%) adult patients with reports of adverse reactions of neutropenia, 19 patients discontinued b
Eintrag öffnenBreyanzi · 4.8 · 13 febrile neutropenia (2%), pyrexia (2%), aphasia (2%), headache (2%), confusional state (2%), pulmonary embo
Eintrag öffnenBreyanzi · 4.8 · 18 Febrile neutropenia and infections Febrile neutropenia has been observed in 7% and 9% of patients who recei
Eintrag öffnenBreyanzi · 4.8 · The most common Grade 3 or higher adverse reactions included neutropenia (56%), anaemia (38%), thrombocytopeni
Eintrag öffnenBreyanzi · 4.8 · The most common Grade 3 or higher adverse reactions included neutropenia (61%), leukopenia (12%), lymphopenia
Eintrag öffnenBreyanzi · 4.8 · The most common Grade 3 or higher adverse reactions included neutropenia (64%), anaemia (34%), thrombocytopeni
Eintrag öffnenBreyanzi · 4.8 · The most common Grade 3 or higher adverse reactions included neutropenia (68%), thrombocytopenia (33%), anaemi
Eintrag öffnenBreyanzi · 4.8 · The most common adverse reactions of any grade were CRS (61%), neutropenia (59%), anaemia (44%), fatigue (35%)
Eintrag öffnenBreyanzi · 4.8 · The most common adverse reactions of any grade were neutropenia (68%), CRS (58%), anaemia (40%), headache (29%
Eintrag öffnenBreyanzi · 4.8 · The most common adverse reactions of any grade were neutropenia (68%), anaemia (45%), CRS (38%), fatigue (37%)
Eintrag öffnenBreyanzi · 4.8 · The most common adverse reactions of any grade were neutropenia (71%), anaemia (45%), CRS (45%) and thrombocyt
Eintrag öffnenBreyanzi · 4.8 · The most common serious adverse reactions were CRS (12%), neutropenia (3%), bacterial infectious disorders (3%
Eintrag öffnen